×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Halitosis Treatment Market Size

ID: MRFR/Pharma/2493-CR
153 Pages
Kinjoll Dey
August 2017

Halitosis Treatment Market Research Report Information By Indication (Respiratory, Liver, Kidney, Gastrointestinal, Systemic, and Others), By Diagnostic Tests (Halimeter, Gas Chromatography, BANA Test, Β-Galactosidase Activity Assay, and Others), By Drug Treatment (Antacids, Antiseptics, Ranitidine, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Halitosis Treatment Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Halitosis Treatment Size

Halitosis Treatment Market Growth Projections and Opportunities

Halitosis, commonly known as chronic bad breath, is a condition where an unpleasant odor is present in a person's breath and can be noticed by others. This issue can arise from various dental problems, including gum diseases, infections in the mouth or throat (such as sinusitis), dry mouth, smoking, and chronic health conditions like diabetes, liver disorders, or kidney disease. According to the American Dental Association (ADA) and the Mayo Clinic, postnasal drip caused by nose, sinus, and throat problems can also contribute to bad breath. Dry mouth, often linked to alcohol and tobacco use or excessive caffeine consumption, is another culprit. The Centers for Disease Control and Prevention (CDC) consider halitosis as a significant warning sign for periodontal diseases.

The impact of bad breath extends beyond personal discomfort, affecting social interactions and potentially leading to stress and psychological pressure. To address this issue, a variety of oral care products are available in the market. Mouthwashes, mint sprays, toothpaste, and other dental care items are commonly used to combat bad breath. Maintaining good oral hygiene is crucial in preventing dental problems, and major players in the market focus on manufacturing oral care products in different flavors to attract customers while ensuring product quality.

The market for halitosis treatment is witnessing substantial growth, driven by factors such as the increasing prevalence of halitosis and periodontal diseases. The Journal of Natural Science, Biology, and Medicine reports that halitosis is prevalent in more than 50% of the general population. Technological advancements in dentistry, such as the use of breathalyzers to detect levels of bacteria causing bad breath, have further fueled the expansion of the global halitosis market.

In terms of market segmentation, halitosis treatment is categorized based on the type of halitosis, including pathological halitosis and other types like physiological halitosis and halitophobia. Pathological halitosis held the largest market share in 2016, primarily due to the increasing incidence of allergic conditions worldwide. Within pathological halitosis, intraoral pathogenic halitosis represents the largest segment and is expected to grow at a compound annual growth rate (CAGR) of 18.90% during the forecast period from 2017-2023. This indicates a rising demand for treatments targeting specific types of halitosis.

In conclusion, halitosis is a prevalent issue with global implications, affecting individuals both socially and psychologically. The market for halitosis treatment is expanding, driven by the growing prevalence of the condition and advancements in dental technology. Understanding the various causes and types of halitosis is crucial for developing effective treatments and maintaining good oral hygiene to prevent such issues.

Halitosis Treatment Market Size Graph
Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What is the current valuation of the Halitosis Treatment Market?

The Halitosis Treatment Market was valued at 4.89 USD Billion in 2024.

What is the projected market size for the Halitosis Treatment Market by 2035?

The market is projected to reach 14.7 USD Billion by 2035.

What is the expected CAGR for the Halitosis Treatment Market during the forecast period?

The expected CAGR for the Halitosis Treatment Market from 2025 to 2035 is 10.52%.

Which companies are the key players in the Halitosis Treatment Market?

Key players include Colgate-Palmolive, Procter & Gamble, Unilever, Johnson & Johnson, and GlaxoSmithKline.

What are the major segments of the Halitosis Treatment Market?

Major segments include indication, diagnostic tests, and drug treatment.

How much is the Gastrointestinal segment valued at in 2024?

The Gastrointestinal segment was valued at 1.22 USD Billion in 2024.

Market Summary

As per MRFR analysis, the Halitosis Treatment Market Size was estimated at 4.89 USD Billion in 2024. The Halitosis Treatment industry is projected to grow from 5.405 USD Billion in 2025 to 14.7 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 10.52 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Halitosis Treatment Market is experiencing a notable shift towards natural and preventive solutions.

  • The market is witnessing a rise in the use of natural ingredients, reflecting consumer preferences for organic products.
  • Digital health integration is becoming increasingly prevalent, enhancing patient engagement and treatment accessibility.
  • Preventive care is gaining traction, as consumers prioritize maintaining oral hygiene to avoid halitosis.
  • The growing awareness of oral hygiene and the rising incidence of halitosis are driving market expansion, particularly in North America and the Asia-Pacific region.

Market Size & Forecast

2024 Market Size 4.89 (USD Billion)
2035 Market Size 14.7 (USD Billion)
CAGR (2025 - 2035) 10.52%
Largest Regional Market Share in 2024 North America

Major Players

<p>Colgate-Palmolive (US), Procter & Gamble (US), Unilever (GB), Johnson & Johnson (US), GlaxoSmithKline (GB), Church & Dwight (US), Henkel (DE), Listerine (US), Oral-B (US)</p>

Market Trends

The Halitosis Treatment Market is currently experiencing a notable evolution, driven by increasing awareness regarding oral hygiene and the rising prevalence of halitosis among various demographics. This condition, often linked to underlying health issues, has prompted consumers to seek effective solutions. As a result, a diverse array of products, including mouthwashes, chewing gums, and specialized dental care items, are gaining traction. Furthermore, the integration of natural ingredients in these treatments appears to resonate well with health-conscious consumers, who are increasingly inclined towards organic and holistic approaches. This shift suggests a potential transformation in product formulations, as manufacturers adapt to meet changing consumer preferences. In addition, the Halitosis Treatment Market is witnessing a surge in digital health solutions, such as mobile applications and telehealth services, which provide personalized recommendations and support for individuals struggling with bad breath. These technological advancements may enhance consumer engagement and facilitate better management of oral health. Moreover, the growing emphasis on preventive care and education regarding oral hygiene practices indicates a broader trend towards proactive health management. As the market continues to evolve, stakeholders must remain vigilant to emerging trends and consumer demands, ensuring that they offer innovative and effective solutions to address halitosis effectively.

Rise of Natural Ingredients

There is a growing trend towards the use of natural ingredients in halitosis treatments. Consumers are increasingly seeking products that incorporate herbal extracts and essential oils, reflecting a preference for organic solutions. This shift may lead manufacturers to reformulate existing products to align with these consumer preferences.

Digital Health Integration

The integration of digital health solutions is becoming more prevalent in the Halitosis Treatment Market. Mobile applications and telehealth services are emerging as valuable tools for consumers, offering personalized advice and tracking capabilities. This trend suggests a potential for enhanced consumer engagement and improved management of oral health.

Focus on Preventive Care

A notable emphasis on preventive care is shaping the Halitosis Treatment Market. Consumers are becoming more aware of the importance of maintaining oral hygiene to prevent bad breath. This trend may drive demand for educational resources and preventive products, encouraging proactive health management.

Halitosis Treatment Market Market Drivers

Rising Incidence of Halitosis

The rising incidence of halitosis is a critical driver for the Halitosis Treatment Market. Factors such as poor dietary habits, smoking, and certain medical conditions have contributed to an increase in the prevalence of bad breath among the population. Research indicates that approximately 25% of adults experience halitosis at some point in their lives, creating a substantial market for treatment options. This growing incidence is prompting consumers to seek effective solutions, thereby driving demand for products such as mouthwashes, chewing gums, and breath sprays. Consequently, the Halitosis Treatment Market is likely to witness robust growth as it responds to the needs of an expanding consumer base.

Expansion of E-commerce Platforms

The expansion of e-commerce platforms is transforming the Halitosis Treatment Market. With the increasing reliance on online shopping, consumers are now able to access a wider range of halitosis treatment products from the comfort of their homes. This shift has been accelerated by the convenience and accessibility that e-commerce offers, allowing consumers to compare products and read reviews before making a purchase. Market data shows that online sales of oral care products have surged by 30% in recent years. As a result, manufacturers are increasingly focusing on their online presence and digital marketing strategies to capture this growing segment of the market, thereby enhancing the overall growth potential of the Halitosis Treatment Market.

Increasing Awareness of Oral Hygiene

The rising awareness regarding oral hygiene is a pivotal driver for the Halitosis Treatment Market. As individuals become more informed about the implications of poor oral health, the demand for effective halitosis treatments is likely to surge. Educational campaigns and initiatives by dental associations have contributed to this heightened awareness, emphasizing the importance of regular dental check-ups and proper oral care. This trend is reflected in market data, which indicates a steady increase in the sales of mouthwashes and breath fresheners, projected to reach USD 2 billion by 2026. Consequently, the Halitosis Treatment Market is expected to benefit from this growing consumer consciousness, leading to an expansion in product offerings and innovations.

Technological Advancements in Dental Care

Technological advancements in dental care are significantly influencing the Halitosis Treatment Market. Innovations such as smart toothbrushes, mobile applications for oral health tracking, and advanced diagnostic tools are enhancing the effectiveness of halitosis treatments. These technologies not only improve the accuracy of diagnosing halitosis but also facilitate personalized treatment plans for patients. Market data suggests that the integration of technology in dental care has led to a 15% increase in the adoption of oral health products. As consumers increasingly seek out technologically advanced solutions, the Halitosis Treatment Market is poised for growth, with manufacturers investing in research and development to create cutting-edge products.

Growing Demand for Natural and Organic Products

The growing demand for natural and organic products is reshaping the Halitosis Treatment Market. Consumers are increasingly gravitating towards products that are free from synthetic chemicals and artificial additives. This trend is driven by a broader movement towards health and wellness, where individuals prioritize natural ingredients for their oral care routines. Market data indicates that the organic oral care segment is expected to grow at a CAGR of 10% over the next five years. As a result, manufacturers are reformulating their products to include natural ingredients such as essential oils and herbal extracts, thereby catering to the evolving preferences of consumers in the Halitosis Treatment Market.

Market Segment Insights

Halitosis Treatment Market Indication Insights

Based on indication, the Halitosis Treatment Market segmentation includes respiratory, liver, kidney,

gastrointestinal,

systemic, and others. The liver segment dominated the market, accounting for 35% of market revenue. Trimethylamine is more prevalent in cirrhotic patients, which leads to bad breath. One of the odd symptoms of fatty liver disease is "breath of the dead." The Fetor hepaticus, often known as the breath of the dead, is a lingering odor that differs from typical breath. Hepatitis and liver failure are intimately connected to fetor hepaticus. 

Organ-related bad breath is typically caused by a sickness or food that interacts with blood levels and generates an odor. Since liver illnesses and bad breath are frequently linked, the rise in liver diseases is anticipated to accelerate the segment's growth throughout the projected period.

Halitosis Treatment Market Diagnostic Tests Insights

Based on diagnostic tests, the Halitosis Treatment Market segmentation includes an altimeter, gas

chromatography

, BANA test, and Β-galactosidase activity assay. The BANA test segment dominated the market. The BANA test assesses the proteolytic activity of certain oral anaerobes that contribute to oral malodor. It refers to the enzymatic breakdown of [N-benzoyl-dL-arginine-2-napthylamide]. Treponema denticola, Prophyromona gingivitis, and Bacteroides forsythias (Red complex) are a few bacteria that create waste products that are highly odiferous and, as a result, contribute to foul breath. The N-benzoyl enzyme is destroyed when a patient's saliva sample containing these bacteria is added to the BANA testing chemical. The test substance changes color due to this biodegradation, indicating a successful response.

Halitosis Treatment Market Drug Treatment Insights

The Halitosis Treatment Market segmentation, based on Drug Treatment, includes antacids, antiseptics, ranitidine, and others. The antacids generated the most income. Antacids are frequently used since they are affordable and help to reduce the discomfort, irritation, edema, and inflammation brought on by heartburn. Additionally, several product advancements, such as creating powerful and safe raft-forming antacids that offer improved efficacy and a longer duration of action, are boosting the market's expansion. The market is expected to develop due to the increasing use of chewable tablets in various flavors that are convenient to store, deliver the right dosage, and enhance patient adherence.

Figure 1: Halitosis Treatment Market, by Drug Treatment, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Get more detailed insights about Halitosis Treatment Market Research Report- Forecast till 2035

Regional Insights

North America : Market Leader in Halitosis Treatment Market

North America is the largest market for halitosis treatment, accounting for approximately 40% of the global share. The region's growth is driven by increasing awareness of oral hygiene, rising disposable incomes, and a growing aging population. Regulatory support from health organizations promoting oral health initiatives further catalyzes market expansion. The demand for innovative products, including mouthwashes and breath fresheners, is on the rise, reflecting changing consumer preferences. The competitive landscape in North America is robust, with key players like Colgate-Palmolive, Procter & Gamble, and Johnson & Johnson leading the market. These companies invest heavily in research and development to introduce new products that cater to consumer needs. The presence of established brands and a strong distribution network enhances market accessibility, ensuring that consumers have a wide range of options for halitosis treatment.

Europe : Emerging Market with Growth Potential

Europe is witnessing significant growth in the halitosis treatment market, holding approximately 30% of the global share. Factors such as increasing health consciousness, a rise in dental care awareness, and the influence of social media on personal grooming are driving demand. Regulatory bodies in Europe are also emphasizing the importance of oral health, which is expected to further boost market growth. The region's diverse population and varying consumer preferences create opportunities for tailored products. Leading countries in Europe include Germany, the UK, and France, where the presence of major players like Unilever and GlaxoSmithKline is notable. The competitive landscape is characterized by a mix of established brands and emerging companies focusing on innovative solutions. The market is also seeing a trend towards natural and organic products, reflecting changing consumer preferences towards healthier options.

Asia-Pacific : Rapidly Growing Market Segment

Asia-Pacific is rapidly emerging as a significant market for halitosis treatment, accounting for approximately 25% of the global share. The growth is driven by increasing urbanization, rising disposable incomes, and a growing awareness of oral hygiene among consumers. Countries like China and India are witnessing a surge in demand for oral care products, supported by government initiatives promoting dental health. The region's diverse demographics also contribute to varied product preferences, enhancing market potential. Key players in the Asia-Pacific market include Colgate-Palmolive and Procter & Gamble, which are expanding their product lines to cater to local tastes. The competitive landscape is evolving, with both multinational corporations and local brands vying for market share. The increasing penetration of e-commerce platforms is also facilitating access to a wider range of halitosis treatment options for consumers in this region.

Middle East and Africa : Untapped Market with Opportunities

The Middle East and Africa region represents an untapped market for halitosis treatment, holding approximately 5% of the global share. The growth potential is significant, driven by increasing urbanization, rising disposable incomes, and a growing awareness of oral health. Regulatory initiatives aimed at improving healthcare access and promoting oral hygiene are expected to catalyze market growth. The region's diverse cultures and lifestyles also create opportunities for tailored products that meet specific consumer needs. Leading countries in this region include South Africa and the UAE, where the presence of key players like Henkel and Church & Dwight is notable. The competitive landscape is characterized by a mix of local and international brands, with a focus on affordability and accessibility. As awareness of halitosis treatment options increases, the market is poised for substantial growth in the coming years.

Key Players and Competitive Insights

Leading market companies are extensively spending R&D on increasing their product lines, which will help the Halitosis Treatment Market grow even more. Important market developments include new product releases, acquisitions and mergers, contractual agreements, greater investments, and collaboration with other organizations. The Halitosis Treatment industry must produce cost-effective merchandise to flourish and thrive in a more competitive and increasing market climate.

Manufacturing locally to reduce operating costs is an effective business strategy manufacturers use in the worldwide Halitosis Treatment industry to serve clients and expand the market sector. The Halitosis Treatment industry has provided some of the most important benefits recently. Church & Dwight., Colgate-Palmolive, and other major companies in the Halitosis Treatment Market are aiming to enhance market demand by investing in research and development activities

American consumer goods corporation Colgate-Palmolive has its main office on Park Avenue in Midtown Manhattan, New York City. Production, distribution, and provision of domestic, health, personal care, and veterinary items are the company's areas of expertise. The biggest manufacturer of soap and detergent in the world, Procter & Gamble (P&G), has long been a rival of Colgate-Palmolive. Following World War II, P&G launched their Tide laundry detergent, which attracted thousands of customers away from Colgate's soaps. When P&G introduced fluoride to their toothpaste, Colgate lost its top spot in the market (Colgate has subsequently reclaimed the top sales spot).

In May 2021, In the United States, Colgate's Hello Products debuted fresh, natural, and eco-friendly oral care items like a reusable toothbrush, floss flavored with peppermint oil and coconut oil, tablets that freshen breath, and mouthwashes.

The market leader in home and personal care goods is Church & Dwight. ARM & HAMMER, Batiste, OxiClean, Trojan, XTRA, Nair, First Response, Spinbrush, Orajel, vita fusion, Li'l Critters, Water Pik, FLAWLESS, Zicam, and TheraBreath are just a few of our internationally recognized brands. They were established in 1846, operate internationally, and are included in the S&P 500. At Church & Dwight, they fuel people's daily lives by offering high-quality, cost-effective consumer goods. Where impact meets ambition is here. They are proud to be experts in our fields. Their team of highly skilled individuals innovates and concentrates on innovative methods.

In November 2021, Church & Dwight Co., Inc. signed a legally binding contract to buy the TheraBreath name. TheraBreath is the second most popular brand of alcohol-free mouthwash in the US. Therefore, these advancements will probably help the market in North America flourish.

Key Companies in the Halitosis Treatment Market market include

Industry Developments

  • Q2 2024: TheraBreath Launches New Oral Rinse Targeting Halitosis TheraBreath announced the launch of a new oral rinse specifically formulated to target halitosis, expanding its product portfolio in the oral care market.
  • Q2 2024: GSK Introduces Sensodyne Fresh Breath Toothpaste for Halitosis Relief GlaxoSmithKline launched Sensodyne Fresh Breath Toothpaste, designed to address halitosis while providing sensitivity relief, marking a new addition to its oral health product line.
  • Q3 2024: Oral Science Announces Partnership with Dental Clinics for Halitosis Treatment Market Program Oral Science entered into a partnership with a network of dental clinics to implement a specialized halitosis treatment program using its proprietary products.
  • Q3 2024: Colgate-Palmolive Expands Manufacturing Facility for Halitosis Treatment Market Products Colgate-Palmolive announced the expansion of its manufacturing facility in New Jersey to increase production capacity for its halitosis treatment product line.
  • Q4 2024: FDA Approves New Prescription Mouthwash for Chronic Halitosis The U.S. FDA approved a new prescription mouthwash developed for chronic halitosis, marking a regulatory milestone for advanced oral care therapeutics.
  • Q4 2024: Johnson & Johnson Acquires BreathRx Brand to Strengthen Halitosis Portfolio Johnson & Johnson completed the acquisition of the BreathRx brand, enhancing its portfolio of products targeting halitosis and oral malodor.
  • Q1 2025: LISTERINE Launches Advanced Formula for Bad Breath in Asia-Pacific LISTERINE introduced an advanced mouthwash formula targeting bad breath in the Asia-Pacific region, aiming to capture growing demand for halitosis solutions.
  • Q1 2025: Oral Care Startup BreathWell Raises $15M Series A to Develop Halitosis Diagnostic Device BreathWell, a health tech startup, secured $15 million in Series A funding to accelerate development of its non-invasive halitosis diagnostic device.
  • Q2 2025: Procter & Gamble Announces Strategic Partnership with Dental Chain for Halitosis Education Procter & Gamble formed a strategic partnership with a major dental chain to launch a halitosis education and treatment initiative across multiple clinics.
  • Q2 2025: FreshBreath Technologies Files for IPO to Fund Halitosis Treatment Market Product Expansion FreshBreath Technologies filed for an initial public offering, aiming to raise capital for expanding its halitosis treatment product line and global distribution.
  • Q3 2025: Dentek Unveils New Tongue Cleaner for Halitosis Prevention Dentek launched a new tongue cleaner designed to help prevent halitosis, broadening its oral hygiene product offerings.
  • Q3 2025: Novartis Receives European Approval for Halitosis Treatment Market Tablet Novartis received regulatory approval in Europe for its new tablet indicated for the treatment of halitosis, expanding its presence in the oral care therapeutics market.

Future Outlook

Halitosis Treatment Market Future Outlook

<p>The Halitosis Treatment Market is projected to grow at a 10.52% CAGR from 2024 to 2035, driven by increasing awareness and innovative treatment options.</p>

New opportunities lie in:

  • <p>Development of personalized oral care products</p>
  • <p>Expansion of telehealth consultations for halitosis</p>
  • <p>Integration of AI-driven diagnostics in dental practices</p>

<p>By 2035, the market is expected to be robust, reflecting substantial growth and innovation.</p>

Market Segmentation

Halitosis Treatment Market Indication Outlook

  • Respiratory
  • Liver
  • Kidney
  • Gastrointestinal
  • Systemic
  • Others

Halitosis Treatment Market Drug Treatment Outlook

  • Antacids
  • Antiseptics
  • Ranitidine
  • Others

Halitosis Treatment Market Diagnostic Tests Outlook

  • Halimeter
  • Gas Chromatography
  • BANA Test
  • Β-Galactosidase Activity Assay
  • Others

Report Scope

MARKET SIZE 20244.89(USD Billion)
MARKET SIZE 20255.405(USD Billion)
MARKET SIZE 203514.7(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)10.52% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesEmergence of innovative oral care products targeting specific halitosis causes presents growth potential in the Halitosis Treatment Market.
Key Market DynamicsRising consumer awareness drives demand for innovative halitosis treatments, influencing market competition and product development.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Halitosis Treatment Market?

The Halitosis Treatment Market was valued at 4.89 USD Billion in 2024.

What is the projected market size for the Halitosis Treatment Market by 2035?

The market is projected to reach 14.7 USD Billion by 2035.

What is the expected CAGR for the Halitosis Treatment Market during the forecast period?

The expected CAGR for the Halitosis Treatment Market from 2025 to 2035 is 10.52%.

Which companies are the key players in the Halitosis Treatment Market?

Key players include Colgate-Palmolive, Procter & Gamble, Unilever, Johnson & Johnson, and GlaxoSmithKline.

What are the major segments of the Halitosis Treatment Market?

Major segments include indication, diagnostic tests, and drug treatment.

How much is the Gastrointestinal segment valued at in 2024?

The Gastrointestinal segment was valued at 1.22 USD Billion in 2024.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Healthcare, BY Indication (USD Billion)
      1. Respiratory
      2. Liver
      3. Kidney
      4. Gastrointestinal
      5. Systemic
      6. Others
    2. Healthcare, BY Diagnostic Tests (USD Billion)
      1. Halimeter
      2. Gas Chromatography
      3. BANA Test
      4. Β-Galactosidase Activity Assay
      5. Others
    3. Healthcare, BY Drug Treatment (USD Billion)
      1. Antacids
      2. Antiseptics
      3. Ranitidine
      4. Others
    4. Healthcare, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. Colgate-Palmolive (US)
      2. Procter & Gamble (US)
      3. Unilever (GB)
      4. Johnson & Johnson (US)
      5. GlaxoSmithKline (GB)
      6. Church & Dwight (US)
      7. Henkel (DE)
      8. Listerine (US)
      9. Oral-B (US)
    3. Appendix
      1. References
      2. Related Reports
  6. LIST OF FIGURES
    1. MARKET SYNOPSIS
    2. NORTH AMERICA MARKET ANALYSIS
    3. US MARKET ANALYSIS BY INDICATION
    4. US MARKET ANALYSIS BY DIAGNOSTIC TESTS
    5. US MARKET ANALYSIS BY DRUG TREATMENT
    6. CANADA MARKET ANALYSIS BY INDICATION
    7. CANADA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    8. CANADA MARKET ANALYSIS BY DRUG TREATMENT
    9. EUROPE MARKET ANALYSIS
    10. GERMANY MARKET ANALYSIS BY INDICATION
    11. GERMANY MARKET ANALYSIS BY DIAGNOSTIC TESTS
    12. GERMANY MARKET ANALYSIS BY DRUG TREATMENT
    13. UK MARKET ANALYSIS BY INDICATION
    14. UK MARKET ANALYSIS BY DIAGNOSTIC TESTS
    15. UK MARKET ANALYSIS BY DRUG TREATMENT
    16. FRANCE MARKET ANALYSIS BY INDICATION
    17. FRANCE MARKET ANALYSIS BY DIAGNOSTIC TESTS
    18. FRANCE MARKET ANALYSIS BY DRUG TREATMENT
    19. RUSSIA MARKET ANALYSIS BY INDICATION
    20. RUSSIA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    21. RUSSIA MARKET ANALYSIS BY DRUG TREATMENT
    22. ITALY MARKET ANALYSIS BY INDICATION
    23. ITALY MARKET ANALYSIS BY DIAGNOSTIC TESTS
    24. ITALY MARKET ANALYSIS BY DRUG TREATMENT
    25. SPAIN MARKET ANALYSIS BY INDICATION
    26. SPAIN MARKET ANALYSIS BY DIAGNOSTIC TESTS
    27. SPAIN MARKET ANALYSIS BY DRUG TREATMENT
    28. REST OF EUROPE MARKET ANALYSIS BY INDICATION
    29. REST OF EUROPE MARKET ANALYSIS BY DIAGNOSTIC TESTS
    30. REST OF EUROPE MARKET ANALYSIS BY DRUG TREATMENT
    31. APAC MARKET ANALYSIS
    32. CHINA MARKET ANALYSIS BY INDICATION
    33. CHINA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    34. CHINA MARKET ANALYSIS BY DRUG TREATMENT
    35. INDIA MARKET ANALYSIS BY INDICATION
    36. INDIA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    37. INDIA MARKET ANALYSIS BY DRUG TREATMENT
    38. JAPAN MARKET ANALYSIS BY INDICATION
    39. JAPAN MARKET ANALYSIS BY DIAGNOSTIC TESTS
    40. JAPAN MARKET ANALYSIS BY DRUG TREATMENT
    41. SOUTH KOREA MARKET ANALYSIS BY INDICATION
    42. SOUTH KOREA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    43. SOUTH KOREA MARKET ANALYSIS BY DRUG TREATMENT
    44. MALAYSIA MARKET ANALYSIS BY INDICATION
    45. MALAYSIA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    46. MALAYSIA MARKET ANALYSIS BY DRUG TREATMENT
    47. THAILAND MARKET ANALYSIS BY INDICATION
    48. THAILAND MARKET ANALYSIS BY DIAGNOSTIC TESTS
    49. THAILAND MARKET ANALYSIS BY DRUG TREATMENT
    50. INDONESIA MARKET ANALYSIS BY INDICATION
    51. INDONESIA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    52. INDONESIA MARKET ANALYSIS BY DRUG TREATMENT
    53. REST OF APAC MARKET ANALYSIS BY INDICATION
    54. REST OF APAC MARKET ANALYSIS BY DIAGNOSTIC TESTS
    55. REST OF APAC MARKET ANALYSIS BY DRUG TREATMENT
    56. SOUTH AMERICA MARKET ANALYSIS
    57. BRAZIL MARKET ANALYSIS BY INDICATION
    58. BRAZIL MARKET ANALYSIS BY DIAGNOSTIC TESTS
    59. BRAZIL MARKET ANALYSIS BY DRUG TREATMENT
    60. MEXICO MARKET ANALYSIS BY INDICATION
    61. MEXICO MARKET ANALYSIS BY DIAGNOSTIC TESTS
    62. MEXICO MARKET ANALYSIS BY DRUG TREATMENT
    63. ARGENTINA MARKET ANALYSIS BY INDICATION
    64. ARGENTINA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    65. ARGENTINA MARKET ANALYSIS BY DRUG TREATMENT
    66. REST OF SOUTH AMERICA MARKET ANALYSIS BY INDICATION
    67. REST OF SOUTH AMERICA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    68. REST OF SOUTH AMERICA MARKET ANALYSIS BY DRUG TREATMENT
    69. MEA MARKET ANALYSIS
    70. GCC COUNTRIES MARKET ANALYSIS BY INDICATION
    71. GCC COUNTRIES MARKET ANALYSIS BY DIAGNOSTIC TESTS
    72. GCC COUNTRIES MARKET ANALYSIS BY DRUG TREATMENT
    73. SOUTH AFRICA MARKET ANALYSIS BY INDICATION
    74. SOUTH AFRICA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    75. SOUTH AFRICA MARKET ANALYSIS BY DRUG TREATMENT
    76. REST OF MEA MARKET ANALYSIS BY INDICATION
    77. REST OF MEA MARKET ANALYSIS BY DIAGNOSTIC TESTS
    78. REST OF MEA MARKET ANALYSIS BY DRUG TREATMENT
    79. KEY BUYING CRITERIA OF HEALTHCARE
    80. RESEARCH PROCESS OF MRFR
    81. DRO ANALYSIS OF HEALTHCARE
    82. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    83. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    84. SUPPLY / VALUE CHAIN: HEALTHCARE
    85. HEALTHCARE, BY INDICATION, 2024 (% SHARE)
    86. HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Billion)
    87. HEALTHCARE, BY DIAGNOSTIC TESTS, 2024 (% SHARE)
    88. HEALTHCARE, BY DIAGNOSTIC TESTS, 2024 TO 2035 (USD Billion)
    89. HEALTHCARE, BY DRUG TREATMENT, 2024 (% SHARE)
    90. HEALTHCARE, BY DRUG TREATMENT, 2024 TO 2035 (USD Billion)
    91. BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. LIST OF ASSUMPTIONS
    2. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    3. US MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    4. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    5. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    6. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    7. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    8. France MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    9. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    10. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    11. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    12. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    13. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    14. China MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    15. India MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    16. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    17. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    18. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    19. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    20. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    21. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    22. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    23. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    24. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    25. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    26. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    27. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    28. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    29. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    30. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY INDICATION, 2025-2035 (USD Billion)
      2. BY DIAGNOSTIC TESTS, 2025-2035 (USD Billion)
      3. BY DRUG TREATMENT, 2025-2035 (USD Billion)
    31. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    32. ACQUISITION/PARTNERSHIP

Market Segmentation

Halitosis Treatment Indication Outlook (USD Billion, 2018-2032)

  • Respiratory
  • Liver
  • Kidney
  • Gastrointestinal
  • Systemic
  • Others

Halitosis Treatment Diagnostic Tests Outlook (USD Billion, 2018-2032)

  • Halimeter
  • Gas Chromatography
  • BANA Test
  • Β-Galactosidase Activity Assay
  • Others

Halitosis Treatment Drug Treatment Outlook (USD Billion, 2018-2032)

  • Antacids
  • Antiseptics
  • Ranitidine
  • Others

Halitosis Treatment Regional Outlook (USD Billion, 2018-2032)

  • North America Outlook (USD Billion, 2018-2032)

    • North America Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • North America Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • North America Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • US Outlook (USD Billion, 2018-2032)

    • US Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • US Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • US Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • CANADA Outlook (USD Billion, 2018-2032)

    • CANADA Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • CANADA Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • CANADA Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

  • Europe Outlook (USD Billion, 2018-2032)

    • Europe Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Europe Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Europe Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • Germany Outlook (USD Billion, 2018-2032)

    • Germany Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Germany Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Germany Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • France Outlook (USD Billion, 2018-2032)

    • France Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • France Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • France Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • UK Outlook (USD Billion, 2018-2032)

    • UK Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • UK Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • UK Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • ITALY Outlook (USD Billion, 2018-2032)

    • ITALY Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • ITALY Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • ITALY Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • SPAIN Outlook (USD Billion, 2018-2032)

    • Spain Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Spain Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Spain Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • Rest Of Europe Outlook (USD Billion, 2018-2032)

    • Rest Of Europe Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Rest Of Europe Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Rest Of Europe Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

  • Asia-Pacific Outlook (USD Billion, 2018-2032)

    • Asia-Pacific Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Asia-Pacific Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Asia-Pacific Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • China Outlook (USD Billion, 2018-2032)

    • China Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • China Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • China Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • Japan Outlook (USD Billion, 2018-2032)

    • Japan Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Japan Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Japan Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • India Outlook (USD Billion, 2018-2032)

    • India Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • India Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • India Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • Australia Outlook (USD Billion, 2018-2032)

    • Australia Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Australia Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Australia Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

    • Rest of Asia-Pacific Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Rest of Asia-Pacific Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Rest of Asia-Pacific Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

  • Rest of the World Outlook (USD Billion, 2018-2032)

    • Rest of the World Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Rest of the World Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Rest of the World Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • Middle East Outlook (USD Billion, 2018-2032)

    • Middle East Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Middle East Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Middle East Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • Africa Outlook (USD Billion, 2018-2032)

    • Africa Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Africa Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Africa Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others

    • Latin America Outlook (USD Billion, 2018-2032)

    • Latin America Halitosis Treatment by Indication
      • Respiratory
      • Liver
      • Kidney
      • Gastrointestinal
      • Systemic
      • Others
    • Latin America Halitosis Treatment by Diagnostic Tests
      • Halimeter
      • Gas Chromatography
      • BANA Test
      • Β-Galactosidase Activity Assay
      • Others
    • Latin America Halitosis Treatment by Drug Treatment
      • Antacids
      • Antiseptics
      • Ranitidine
      • Others
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓